🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is a randomized, double-blind, placebo-controlled, crossover stu...
Status
Completed
Location
Maastricht University
Start Date
2016-07-05
Trial ID
NCT02806895
This trial is a randomized, double-blind, placebo-controlled, crossover stu...
Status
Completed
Location
Maastricht University
Start Date
2016-06
Trial ID
NCT02806908
This is a Phase 3 study to assess the long-term safety and maintenance of e...
Status
Completed
Location
Sleep Disorders Center of Alabama
Start Date
2015-05
Trial ID
NCT02348632
Treatments Being Tested
PARADIGM (Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Us...
Status
Completed
Location
Clinical Research Site
Start Date
2024-03-18
Trial ID
NCT06360419
Treatments Being Tested
ENGAGE (Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Di...
Status
Recruiting
Location
Clinical Research Site
Start Date
2024-04-26
Trial ID
NCT06413433
Treatments Being Tested
This trial is a 12 week, randomized, double-blind, placebo controlled, mult...
Status
Completed
Location
Pulmonary Associates
Start Date
2015-05
Trial ID
NCT02348606
Treatments Being Tested
This Phase II clinical trial is a monocenter, double-blind, randomized, pla...
Status
Not Yet Recruiting
Location
University Hospital of Montpellier
Start Date
2024-09-15
Trial ID
NCT06590662
Treatments Being Tested
This trial is a 12-week, randomized, double-blind, placebo controlled, mult...
Status
Completed
Location
Sleep Disorders Center of Alabama
Start Date
2015-05
Trial ID
NCT02348593
Treatments Being Tested
This study is a 4-week, multicenter, randomized, double-blind, placebo-cont...
Status
Completed
Location
Southern California Institute For Respiratory Diseases, Inc.
Start Date
2017-01
Trial ID
NCT03037203
This phase II trial studies the side effects of solriamfetol in improving s...
Status
Terminated
Location
Wake Forest Baptist Comprehensive Cancer Center
Start Date
2021-01-27
Trial ID
NCT03868943
Treatments Being Tested